Recently, the food allergy community anxiously awaited good news of FDA approval for neffy® (needle-free nasal epinephrine spray), but to the community’s shock, the FDA denied approval. ARS Pharma Co-founder, President and CEO, Richard Lowenthal, joins us to explain what happened and where neffy® stands. Resources to keep you in the know:ARS PharmaStay tuned and follow FAACT to learn how you can take action and personally advocate for the approval of neffy® with your local and federal legislators. You can find the FAACT Roundtable Podcast on Pandora, Apple Podcast, Spotify,  Stitcher, iHeart Radio, Podcast Chaser, Deezer, and Listen Notes.Visit us at www.FoodAllergyAwareness.org.Sponsored by: ARS PharmaThanks for listening! FAACT invites you to discover more exciting food allergy resources at FoodAllergyAwareness.org!

Ver todos los episodios